Jane H. Hsiao, Ph.D.

Jane H. Hsiao, Ph.D.

Chief Technical OfficeratOpko Health· In proxies 2021–2025

Pay in FY2025-15% from the year before · Opko Health stock -14.3% the same year

Jane H. Hsiao, Ph.D. was paid $1.8M in FY2025 (Dec), down 15%. Opko Health stock fell 14.3% that year.

Pay$100 in the stock at the end of FY20 → $32
Pay is from the Summary Compensation Table of each Opko Health proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Opko HealthPublic company · 5 yr
    • Chief Technical Officer2021 – Present · 5 yrStock in role -62%
  2. Non-Invasive Monitoring Systems, Inc.Public company · 18 yr
    • Director2008 – Present · 18 yrNo stock prices for these years
  3. Non-Invasive MonitoringPublic company
    • Director? – PresentNo stock prices for these years
  4. Asensus Surgical, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Cocrystal Pharma, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Neovasc, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • Opko HealthDirector · 18 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?